MAPT and Alzheimer disease: Blocking either Aβ production or reducing p‐Tau level using respective inhibitors could not rescue serum exposure‐induced synaptic loss, suggesting that serum exposure could induce synaptic loss independently of Aβ or p‐Tau level, which may help us to uncover unexplored mechanisms underlying AD pathogenesis in the future.